According to GlobalData’s medical device pipeline database, 30 Hematology Analyzers devices are in various stages of development globally. GlobalData’s report Hematology Analyzers provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 22 are in active development, while the remaining nine are in an inactive stage of development. There are nine products in the early stages of development, and the remaining 13 are in the late stages of development.

Hematology Analyzers consist of analytical laboratory equipment that is used to perform tests related to blood and blood components. Hematology analyzers are also used to identify and determine morphology of blood and blood-forming cells such as white blood cells, lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Hematology analyzers utilize various technological solutions in order to recognize cell types in a blood sample and to count them individually to generate a complete blood count (CBC) with differential. The Hematology analyzers market includes the sub-segments, High-throughput Fixed Hematology Analyzers, Medium-throughput Fixed Hematology Analyzers and Bench Top Point of Care (POC) Hematology Analyzers. One unit refers to One hematology analyzer.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Hematology Analyzers pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Hematology Analyzers devices. Overall, most of these Hematology Analyzers pipeline devices are being developed by private entities.

Key players involved in the active development of Hematology Analyzers include Daxor, MicroX Labs, Diatron Medical Instruments, Sysmex, University of British Columbia, Trinity Biotech, iFirst Medical Technologies, Ionu Biosystems, IRIS International and I-Sens.

For a complete picture of the developmental pipeline for Hematology Analyzers devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.